{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:51:41Z","timestamp":1789487501412,"version":"build-2803163510"},"reference-count":53,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Regional data on steatotic liver disease (SLD) in people with HIV (PWH) are scarce. This study aimed to determine the prevalence of SLD phenotypes and clinically significant fibrosis (CSF) in a cohort of Egyptian PWH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted on 531 PWH who attended the HIV clinic at Cairo University Hospitals between July 2022 and September 2023. Hepatic steatosis and fibrosis were assessed using vibration-controlled transient elastography (FibroScan). SLD was defined by a controlled attenuation parameter (CAP) \u2265248\u00a0dB\/m and CSF was defined by a liver stiffness measurement (LSM) \u22658\u00a0kPa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of SLD was 26.0% (n=138\/531), with metabolic dysfunction-associated SLD (MASLD) as the predominant phenotype (81.15%) followed by hepatitis C virus (HCV)-associated SLD (12.31%). The prevalence of CSF was significantly higher in patients with SLD (15.22%) compared with those without (3.56%). The risk for CSF was greatest among patients with HCV-associated SLD, with or without cardiometabolic risk factors (23.53%), followed by those with MASLD (15.18%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SLD is a common comorbidity among PWH in Egypt, predominantly driven by metabolic dysfunction. CSF was notably higher among those with MASLD and HCV coinfection, underscoring the need for integrating systematic SLD assessment into routine HIV care to enable early detection and management of progressive liver disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/trstmh\/trag110","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:29:52Z","timestamp":1788521392000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of steatotic liver disease phenotypes and liver fibrosis in people with HIV in Egypt"],"prefix":"10.1093","author":[{"given":"Ahmed","family":"Cordie","sequence":"first","affiliation":[{"name":"Cairo University Cairo University Hospitals HIV Clinic, Endemic Medicine Department, , Cairo, 11956 ,","place":["Egypt"]},{"name":"Kasr Al-Aini HIV and Viral Hepatitis Fighting Group, Cairo University Hospitals , Cairo, 11956 ,","place":["Egypt"]},{"name":"Armed Forces College of Medicine Infectious Diseases Department, , Cairo, 11765 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9528-2674","authenticated-orcid":false,"given":"Rahma","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Cairo University Hospitals HIV Clinic , Endemic Medicine Department, Cairo University, Cairo, 11956 ,","place":["Egypt"]},{"name":"Kasr Al-Aini HIV and Viral Hepatitis Fighting Group, Cairo University Hospitals , Cairo, 11956 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Sebastiani","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, McGill University Health Centre , Montreal, H4A 3J1 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeema","family":"El\u00a0Garhy","sequence":"additional","affiliation":[{"name":"Cairo University Hospitals HIV Clinic , Endemic Medicine Department, Cairo University, Cairo, 11956 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamiaa","family":"Al\u00a0Sehemy","sequence":"additional","affiliation":[{"name":"Cairo University Hospitals HIV Clinic , Endemic Medicine Department, Cairo University, Cairo, 11956 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Saweres","sequence":"additional","affiliation":[{"name":"Cairo University Hospitals HIV Clinic , Endemic Medicine Department, Cairo University, Cairo, 11956 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S","family":"Nagy","sequence":"additional","affiliation":[{"name":"Cairo University Hospitals HIV Clinic , Endemic Medicine Department, Cairo University, Cairo, 11956 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham Awad","family":"Awad","sequence":"additional","affiliation":[{"name":"Cairo University Hospitals HIV Clinic , Endemic Medicine Department, Cairo University, Cairo, 11956 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remon","family":"Atef","sequence":"additional","affiliation":[{"name":"Cairo University Hospitals HIV Clinic , Endemic Medicine Department, Cairo University, Cairo, 11956 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya M","family":"Al-sharif","sequence":"additional","affiliation":[{"name":"Cairo University Hospitals HIV Clinic , Endemic Medicine Department, Cairo University, Cairo, 11956 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Y","family":"Awadh","sequence":"additional","affiliation":[{"name":"Freelance Medical Writer , Cairo, 11765 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Ramadan","sequence":"additional","affiliation":[{"name":"School of Medicine, New Giza University , Cairo, 16623 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angee","family":"Al-Shayeb","sequence":"additional","affiliation":[{"name":"School of Medicine, New Giza University , Cairo, 16623 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engy","family":"El\u00a0Khateeb","sequence":"additional","affiliation":[{"name":"Cairo University Clinical and Chemical Pathology Department, Faculty of Medicine, , Cairo, 11956 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend Hamed","family":"Tamim","sequence":"additional","affiliation":[{"name":"Cairo University Clinical and Chemical Pathology Department, Faculty of Medicine, , Cairo, 11956 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania Soliman","family":"Hamza","sequence":"additional","affiliation":[{"name":"Cairo University Clinical and Chemical Pathology Department, Faculty of Medicine, , Cairo, 11956 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"El\u00a0Saadany","sequence":"additional","affiliation":[{"name":"Cairo University Clinical and Chemical Pathology Department, Faculty of Medicine, , Cairo, 11956 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Esmat","sequence":"additional","affiliation":[{"name":"Cairo University Endemic Medicine and Hepatology Department, Faculty of Medicine, , Cairo, 11956 ,","place":["Egypt"]},{"name":"Research Center, Badr University in Cairo , Badr City, Cairo, 11829 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Omar","sequence":"additional","affiliation":[{"name":"Cairo University Endemic Medicine and Hepatology Department, Faculty of Medicine, , Cairo, 11956 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"2026091510181457000_bib1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction\u2013associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"key":"2026091510181457000_bib2","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"2026091510181457000_bib3","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"2026091510181457000_bib4","volume-title":"HIV Data and Statistics","author":"World Health Organization","year":"2026"},{"key":"2026091510181457000_bib5","volume-title":"HIV and AIDS Estimates Country Factsheets: Egypt","author":"UNAIDS","year":"2023"},{"key":"2026091510181457000_bib6","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/tmi.13825","article-title":"The \u20184th 90\u2019 target as a strategy to improve health-related quality of life of people living with HIV in sub-Saharan Africa","volume":"27","author":"Mvilongo","year":"2022","journal-title":"Trop Med Int Health"},{"key":"2026091510181457000_bib7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/liv.15852","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa","volume":"44","author":"Younossi","year":"2024","journal-title":"Liver Int"},{"key":"2026091510181457000_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"2026091510181457000_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cgh.2020.10.018","article-title":"Expert panel review on nonalcoholic fatty liver disease in persons with human immunodeficiency virus","volume":"20","author":"Lake","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091510181457000_bib10","doi-asserted-by":"crossref","first-page":"e0191985","DOI":"10.1371\/journal.pone.0191985","article-title":"Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection","volume":"13","author":"Benmassaoud","year":"2018","journal-title":"PLoS One"},{"key":"2026091510181457000_bib11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11606-008-0594-0","article-title":"Effectiveness of the AUDIT-C as a screening test for alcohol misuse in three race\/ethnic groups","volume":"23","author":"Frank","year":"2008","journal-title":"J Gen Intern Med"},{"key":"2026091510181457000_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1530-0277.2003.tb02723.x","article-title":"Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE, and CRAFFT","volume":"27","author":"Knight","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"2026091510181457000_bib13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1478-3231.2012.02781.x","article-title":"Controlled attenuation parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography","volume":"32","author":"Myers","year":"2012","journal-title":"Liver Int"},{"key":"2026091510181457000_bib14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"2026091510181457000_bib15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"2026091510181457000_bib16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"2026091510181457000_bib17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026091510181457000_bib18","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1097\/QAD.0000000000003351","article-title":"Controlled attenuation parameter accurately detects liver steatosis in people with HIV","volume":"36","author":"Duarte","year":"2022","journal-title":"AIDS"},{"key":"2026091510181457000_bib19","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/hiv.13542","article-title":"Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023","volume":"24","author":"Ambrosioni","year":"2023","journal-title":"HIV Med"},{"key":"2026091510181457000_bib20","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/HEP.0000000000000313","article-title":"Burden of fatty liver and hepatic fibrosis in persons with HIV: a diverse cross-sectional US multicenter study","volume":"78","author":"Gawrieh","year":"2023","journal-title":"Hepatology"},{"key":"2026091510181457000_bib21","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"2026091510181457000_bib22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J Hepatol"},{"key":"2026091510181457000_bib23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/apt.17849","article-title":"Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States","volume":"59","author":"Gawrieh","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"2026091510181457000_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/0956462420960997","article-title":"Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people","volume":"32","author":"Jongraksak","year":"2021","journal-title":"Int J STD AIDS"},{"key":"2026091510181457000_bib25","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/jgh.15320","article-title":"Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China","volume":"36","author":"Liu","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2026091510181457000_bib26","doi-asserted-by":"crossref","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","article-title":"Global prevalence of nonalcoholic fatty liver disease: an updated review meta-analysis comprising a population of 78 million from 38 countries","volume":"55","author":"Amini-Salehi","year":"2024","journal-title":"Arch Med Res"},{"key":"2026091510181457000_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"2026091510181457000_bib28","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"2026091510181457000_bib29","doi-asserted-by":"crossref","first-page":"101271","DOI":"10.1016\/j.jhepr.2024.101271","article-title":"Global burden of metabolic dysfunction-associated liver disease, 2010 to 2021","volume":"7","author":"Feng","year":"2024","journal-title":"JHEP Reports"},{"key":"2026091510181457000_bib30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2337\/db19-214-LB","article-title":"214-LB: vibration-controlled transient elastography reveals alarming prevalence of nonalcoholic fatty liver disease and fibrosis among young adults in Egypt","volume":"68","author":"Tomah","year":"2019","journal-title":"Diabetes"},{"key":"2026091510181457000_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12879-025-10735-7","article-title":"Prevalence of metabolic syndrome in people living with HIV and its multi-organ damage: a prospective cohort study","volume":"25","author":"Tang","year":"2025","journal-title":"BMC Infect Dis"},{"key":"2026091510181457000_bib32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12879-026-12829-2","article-title":"Prevalence and determinants of cardiometabolic comorbidities among people living with HIV receiving antiretroviral therapy at Zewditu Memorial Hospital: evidence from Ethiopia\u2019s longest serving AIDS clinic","volume":"26","author":"Amdemariam","year":"2026","journal-title":"BMC Infect Dis"},{"key":"2026091510181457000_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12944-024-02317-4","article-title":"MASLD in persons with HIV is associated with high cardiometabolic risk as evidenced by altered advanced lipoprotein profiles and targeted metabolomics","volume":"23","author":"Lin","year":"2024","journal-title":"Lipids Health Dis"},{"key":"2026091510181457000_bib34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/COH.0000000000000952","article-title":"Metabolic dysfunction-associated steatotic liver disease in people with HIV","volume":"20","author":"Gattu","year":"2025","journal-title":"Curr Opin HIV AIDS"},{"key":"2026091510181457000_bib35","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1038\/s41598-023-32965-y","article-title":"Metabolic dysfunction-associated fatty liver disease in people living with HIV","volume":"13","author":"Michel","year":"2023","journal-title":"Sci Rep"},{"key":"2026091510181457000_bib36","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1152\/physrev.00034.2017","article-title":"Impaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity","volume":"98","author":"Hammarstedt","year":"2018","journal-title":"Physiol Rev"},{"key":"2026091510181457000_bib37","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.jhep.2022.08.010","article-title":"Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease","volume":"77","author":"Pafili","year":"2022","journal-title":"J Hepatol"},{"key":"2026091510181457000_bib38","doi-asserted-by":"crossref","first-page":"101122","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol Metab"},{"key":"2026091510181457000_bib39","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/liv.15377","article-title":"Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals","volume":"42","author":"Saponaro","year":"2022","journal-title":"Liver Int"},{"key":"2026091510181457000_bib40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.aohep.2020.03.001","article-title":"Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity","volume":"19","author":"Lonardo","year":"2020","journal-title":"Ann Hepatol"},{"key":"2026091510181457000_bib41","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cgh.2023.01.001","article-title":"Prevalence and characteristics of nonalcoholic fatty liver disease and fibrosis in people living with HIV monoinfection: a systematic review and meta-analysis","volume":"21","author":"Kalligeros","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091510181457000_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11904-024-00708-x","article-title":"Metabolic complications associated with use of integrase strand transfer inhibitors (InSTI) for the treatment of HIV-1 infection: focus on weight changes, lipids, glucose and bone metabolism","volume":"21","author":"Savinelli","year":"2024","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2026091510181457000_bib43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"2026091510181457000_bib44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"key":"2026091510181457000_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajg.2026.02.001","article-title":"Beyond viral elimination: the emerging epidemic of metabolic dysfunction-associated steatotic liver disease (MASLD)\u2013viral hepatitis overlap","volume":"27","author":"Mohamed","year":"2026","journal-title":"Arab J Gastroenterol"},{"key":"2026091510181457000_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.2005.069757","article-title":"Steatosis in chronic hepatitis C: why does it really matter?","volume":"55","author":"Asselah","year":"2006","journal-title":"Gut"},{"key":"2026091510181457000_bib47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2022.01.016","article-title":"Cigarette smoking and liver diseases","volume":"77","author":"Marti-Aguado","year":"2022","journal-title":"J Hepatol"},{"key":"2026091510181457000_bib48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11904-023-00657-x","article-title":"The human microbiome and gut\u2013liver axis in people living with HIV","volume":"20","author":"Duarte","year":"2023","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2026091510181457000_bib49","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/QAD.0000000000004189","article-title":"Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIV","volume":"39","author":"Duarte","year":"2022","journal-title":"AIDS"},{"key":"2026091510181457000_bib50","first-page":"ofae187","article-title":"Microbial translocation and gut damage are associated with an elevated fast score in women living with and without HIV","volume-title":"Open Forum Infect Dis","author":"Duarte","year":"2024"},{"key":"2026091510181457000_bib51","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/gut.2008.163287","article-title":"gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis","volume":"59","author":"Bruno","year":"2010","journal-title":"Gut"},{"key":"2026091510181457000_bib52","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.3390\/ijms15069184","article-title":"Molecular mechanisms of liver fibrosis in HIV\/HCV coinfection","volume":"15","author":"Mastroianni","year":"2014","journal-title":"Int J Mol Sci"},{"key":"2026091510181457000_bib53","doi-asserted-by":"crossref","first-page":"20503121241260613","DOI":"10.1177\/20503121241260613","article-title":"A review of dolutegravir-associated weight gain and secondary metabolic comorbidities","volume":"12","author":"Jemal","year":"2024","journal-title":"SAGE Open Medicine"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/advance-article-pdf\/doi\/10.1093\/trstmh\/trag110\/71089490\/trag110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/advance-article-pdf\/doi\/10.1093\/trstmh\/trag110\/71089490\/trag110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:23:51Z","timestamp":1789482231000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/advance-article\/doi\/10.1093\/trstmh\/trag110\/8796075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":53,"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trag110","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"trag110"}}